However, apart from the SSTR or ZAC1 expressions, differences in the pathogenesis of somatotropinomas and NFPA are also likely to account for the different response to somatostatin analogs in these adenoma subtypes. The gene discussed is SST; the disease is growth hormone-producing pituitary gland neoplasm.